Microbe-driven Development of GALT

Information

  • Research Project
  • 10149917
  • ApplicationId
    10149917
  • Core Project Number
    R01AI140132
  • Full Project Number
    5R01AI140132-04
  • Serial Number
    140132
  • FOA Number
    PAS-15-055
  • Sub Project Id
  • Project Start Date
    5/25/2018 - 6 years ago
  • Project End Date
    4/30/2023 - a year ago
  • Program Officer Name
    ROTHERMEL, ANNETTE L
  • Budget Start Date
    5/1/2021 - 3 years ago
  • Budget End Date
    4/30/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    04
  • Suffix
  • Award Notice Date
    4/29/2021 - 3 years ago

Microbe-driven Development of GALT

Abstract Microbiota are required for the development of secondary lymphoid tissues, including gut- associated lymphoid tissues (GALT). Interactions between GALT and the microbiota are especially important in rabbits, as B cells proliferate and mutate their V(D)J genes in response to select commensal bacteria. Further, VHa B cells, identified because they utilize VH1, are selectively expanded in GALT as a result of specific commensal bacteria. In contrast, other B cells, designated VHn, do not expand in GALT. VHa and VHn B cells differ primarily in the external surface of framework regions (FR) 1 and 3, and we propose that VHa-specific amino acids on the external surfaces of FR1 and FR3 form a binding motif that together with TLR signaling through MyD88, mediates selective expansion of VHa B cells by binding bacterial cell surface molecules. We hypothesize that this innate-like, non-antigen-specific stimulation through the B cell receptor (BCR) facilitates selective expansion of VHa B cells and diversification of the primary Ab repertoire. In Aim 1, we will test this hypothesis by identifying bacteria in GALT that selectively bind to and activate VHa but not VHn B cells. Aim 2 will test if the identified bacteria specifically drive expansion of VHa B cells in vivo; and in Aim 3, we will explore the mechanism by which the bacteria stimulate VHa B cells. The results will elucidate a new mechanism by which bacteria interact with B cells to promote development of the immune system.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R01
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
    299895
  • Indirect Cost Amount
    161693
  • Total Cost
    461588
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIAID:461588\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    CMIB
  • Study Section Name
    Cellular and Molecular Immunology - B Study Section
  • Organization Name
    LOYOLA UNIVERSITY CHICAGO
  • Organization Department
    MICROBIOLOGY/IMMUN/VIROLOGY
  • Organization DUNS
    791277940
  • Organization City
    MAYWOOD
  • Organization State
    IL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    601533328
  • Organization District
    UNITED STATES